A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung.
about
A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Novel Orally Available Asthm ...... g GABAA Receptors in the Lung.
@en
A Novel Orally Available Asthm ...... g GABAA Receptors in the Lung.
@nl
type
label
A Novel Orally Available Asthm ...... g GABAA Receptors in the Lung.
@en
A Novel Orally Available Asthm ...... g GABAA Receptors in the Lung.
@nl
prefLabel
A Novel Orally Available Asthm ...... g GABAA Receptors in the Lung.
@en
A Novel Orally Available Asthm ...... g GABAA Receptors in the Lung.
@nl
P2093
P2860
P50
P1476
A Novel Orally Available Asthm ...... ng GABAA Receptors in the Lung
@en
P2093
Amanda N Nieman
Charles W Emala
Douglas A Steeber
Douglas C Stafford
Gene T Yocum
Gloria S Forkuo
Guanguan Li
Janet L Fisher
M S Rashid Roni
Margaret L Guthrie
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.7B01013
P407
P577
2018-04-02T00:00:00Z